Follow
Hanieh Khalili
Hanieh Khalili
Research Associate, School of Pharmacy and Institute of Ophthalmology, University College London
Verified email at ucl.ac.uk - Homepage
Title
Cited by
Cited by
Year
PEGylation and its impact on the design of new protein-based medicines
C Ginn, H Khalili, R Lever, S Brocchini
Future Medicinal Chemistry 6 (16), 1829-1846, 2014
932014
Comparative binding of disulfide-bridged PEG-Fabs
H Khalili, A Godwin, J Choi, R Lever, S Brocchini
Bioconjugate chemistry 23 (11), 2262-2277, 2012
892012
Fab-PEG-Fab as a potential antibody mimetic
H Khalili, A Godwin, J Choi, R Lever, PT Khaw, S Brocchini
Bioconjugate Chemistry 24 (11), 1870-1882, 2013
542013
Antibody fragments: Prolonging circulation half-life special issue-antibody research
AP Herrington-Symes, M Farys, H Khalili, S Brocchini
Scientific Research Publishing, 2013
442013
Storage stability of bevacizumab in polycarbonate and polypropylene syringes
H Khalili, G Sharma, A Froome, PT Khaw, S Brocchini
Eye 29 (6), 820-827, 2015
372015
An anti-TNF-α antibody mimetic to treat ocular inflammation
H Khalili, RW Lee, PT Khaw, S Brocchini, AD Dick, DA Copland
Scientific reports 6 (1), 36905, 2016
302016
Comparative thermodynamic analysis in solution of a next generation antibody mimetic to VEGF
H Khalili, S Brocchini, PT Khaw, SK Filippov
RSC advances 8 (62), 35787-35793, 2018
142018
Bioengineering of antibody fragments: challenges and opportunities
S Pirkalkhoran, WR Grabowska, HH Kashkoli, R Mirhassani, D Guiliano, ...
Bioengineering 10 (2), 122, 2023
132023
Fc-fusion mimetics
H Khalili, PT Khaw, S Brocchini
Biomaterials science 4 (6), 943-947, 2016
132016
Soluble papain to digest monoclonal antibodies; time and cost-effective method to obtain Fab fragment
M Collins, H Khalili
Bioengineering 9 (5), 209, 2022
62022
Advanced therapy medicinal products for age-related macular degeneration; scaffold fabrication and delivery methods
H Khalili, HH Kashkoli, DE Weyland, S Pirkalkhoran, WR Grabowska
Pharmaceuticals 16 (4), 620, 2023
42023
Chemical and Genetic Modification
M Farys, CL Ginn, GO Badescu, K Peciak, EM Pawlisz, H Khalili, ...
Biological and Drug Products; development and Strategies book, 2013
42013
Dual-acting therapeutic proteins for intraocular use
M Collins, S Awwad, N Ibeanu, PT Khaw, D Guiliano, S Brocchini, ...
Drug Discovery Today 26 (1), 44-55, 2021
32021
Protein modification by bis-alkylation
C Picken, S Awwad, M Zloh, H Khalili, S Brocchini
Polymer-protein conjugates, 351-385, 2020
32020
Using different proteolytic enzymes to digest antibody and its impact on stability of antibody mimetics
H Khalili
Journal of Immunological Methods 489, 112933, 2021
22021
PEGylation and its impact on the design of new protein-based medicines (vol 6, pg 1829, 2014)
C Ginn, H Khalili, R Lever, S Brocchini
FUTURE MEDICINAL CHEMISTRY 6 (18), 2133-2133, 2014
22014
Disulfide-bridging PEGylation of antibody fragments
H Khalili
University College London (University of London), 2012
22012
Soluble Papain to Digest Monoclonal Antibodies; Time and Cost-Effective Method to Obtain Fab Fragment. Bioengineering 2022, 9, 209
M Collins, H Khalili
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022
12022
The increased stability of FpFs compared to monoclonal antibodies
H Khalili, S Brocchini, PT Khaw, A Khalili, G Sharma
Investigative Ophthalmology & Visual Science 56 (7), 377-377, 2015
12015
A Novel Model of Tissue Contraction and Inflammation In Fibrosis After Glaucoma Filtration Surgery
G Sharma, H Khalili, A Khalili, S Brocchini, M Bailly, PT Khaw
Investigative Ophthalmology & Visual Science 56 (7), 927-927, 2015
12015
The system can't perform the operation now. Try again later.
Articles 1–20